MX9204721A - Procedimiento para convertir polisacarido capsular bacterial que contiene lipido en polisacarido libre de lipido. - Google Patents

Procedimiento para convertir polisacarido capsular bacterial que contiene lipido en polisacarido libre de lipido.

Info

Publication number
MX9204721A
MX9204721A MX9204721A MX9204721A MX9204721A MX 9204721 A MX9204721 A MX 9204721A MX 9204721 A MX9204721 A MX 9204721A MX 9204721 A MX9204721 A MX 9204721A MX 9204721 A MX9204721 A MX 9204721A
Authority
MX
Mexico
Prior art keywords
lipid
polysaccharide
procedure
free
bacterial capsular
Prior art date
Application number
MX9204721A
Other languages
English (en)
Inventor
Ann L Lee
Walter E Manger
Mark S Rienstra
Robert D Sitrin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/909,346 external-priority patent/US5314811A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MX9204721A publication Critical patent/MX9204721A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

Un proceso para convertir polisacárido capsular bacterial que contiene lípido, tal como lipo-poliribosil ribitol fosfato, lipo-PRP, el polisacárido libre de endotoxina, libre de lípido, tal como poliribosil ribitol fosfato PRP, al solubilizar polvo que contiene polisacárido derivado del medio de cultivo de bacterias tales como Haemophilus influencia tipo B, escindir ácidos grasos ligados covalentemente del polisacárido y retirar los lípidos y endotoxina.
MX9204721A 1991-08-16 1992-08-14 Procedimiento para convertir polisacarido capsular bacterial que contiene lipido en polisacarido libre de lipido. MX9204721A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74652391A 1991-08-16 1991-08-16
US07/909,346 US5314811A (en) 1992-07-13 1992-07-13 Process for converting lipid-containing bacterial capsular polysaccharide into lipid-free polysaccharide

Publications (1)

Publication Number Publication Date
MX9204721A true MX9204721A (es) 1993-07-01

Family

ID=27114616

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9204721A MX9204721A (es) 1991-08-16 1992-08-14 Procedimiento para convertir polisacarido capsular bacterial que contiene lipido en polisacarido libre de lipido.

Country Status (18)

Country Link
EP (1) EP0528635B1 (es)
JP (1) JPH05209002A (es)
KR (1) KR930004473A (es)
CN (1) CN1071699A (es)
AT (1) ATE176929T1 (es)
AU (1) AU2105492A (es)
BG (1) BG98470A (es)
CA (1) CA2075681C (es)
CZ (1) CZ28694A3 (es)
DE (1) DE69228454T2 (es)
FI (1) FI940700A (es)
HU (1) HU9400426D0 (es)
IL (1) IL102763A0 (es)
MX (1) MX9204721A (es)
NZ (1) NZ243892A (es)
SK (1) SK18594A3 (es)
WO (1) WO1993004183A1 (es)
YU (1) YU89692A (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69731380T2 (de) * 1996-02-14 2006-02-23 Merck & Co., Inc. Verfahren zur präzipitation von polysacchariden
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process
SE0003958D0 (sv) 2000-10-31 2000-10-31 Biogaia Fermentation Ab Method for growth of microorganisms
HU230490B1 (hu) 2001-01-23 2016-08-29 Sanofi Pasteur Inc. Multivalens, meningokokkusz-eredetű poliszaccharid és fehérje konjugátumát tartalmazó vakcina
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
KR100826963B1 (ko) * 2001-11-13 2008-05-02 주식회사 포스코 고로 노심온도 관리 방법
GB0408978D0 (en) * 2004-04-22 2004-05-26 Chiron Srl Meningococcal fermentation for preparing conjugate vaccines
EP2409995A3 (en) * 2007-02-28 2012-08-15 Lipoxen Technologies Limited Reduction of endotoxin in polysialic acids
FR2918671B1 (fr) 2007-07-10 2010-10-15 Sanofi Pasteur Milieu de culture d'haemophilus influenzae type b.
CN101724085B (zh) * 2008-10-22 2011-09-21 上海生物制品研究所 一种荚膜多糖纯化方法
CN103059149B (zh) * 2011-10-19 2016-08-31 天士力制药集团股份有限公司 一种prp多糖提取方法
CN102660602B (zh) * 2012-04-17 2015-03-25 江苏康泰生物医学技术有限公司 快速纯化细菌荚膜多糖的方法
CN102731670B (zh) * 2012-06-29 2014-09-03 成都欧林生物科技股份有限公司 Hib荚膜多糖纯化工艺
MY182282A (en) * 2015-05-04 2021-01-18 Pfizer Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
BR102019021510A2 (pt) * 2019-10-14 2022-01-25 Instituto Butantan Processo de produção, recuperação e purificação de polissacarídeo capsular poliribosil-ribitol-fosfato (prp) e uso do mesmo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2316964A1 (fr) * 1975-07-11 1977-02-04 Pasteur Institut Medicament contenant, a titre de principe actif, un produit a base de polysaccharides, notamment obtenu a partir de lipopolysaccharides bacteriens
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens

Also Published As

Publication number Publication date
BG98470A (en) 1994-12-02
EP0528635B1 (en) 1999-02-24
CN1071699A (zh) 1993-05-05
CZ28694A3 (en) 1994-05-18
AU2105492A (en) 1993-02-18
FI940700A0 (fi) 1994-02-15
SK18594A3 (en) 1994-08-10
YU89692A (sh) 1995-10-24
IL102763A0 (en) 1993-01-31
NZ243892A (en) 1994-06-27
HU9400426D0 (en) 1994-05-30
ATE176929T1 (de) 1999-03-15
WO1993004183A1 (en) 1993-03-04
DE69228454T2 (de) 1999-07-15
KR930004473A (ko) 1993-03-22
DE69228454D1 (de) 1999-04-01
CA2075681C (en) 2003-03-25
JPH05209002A (ja) 1993-08-20
CA2075681A1 (en) 1993-02-17
EP0528635A1 (en) 1993-02-24
FI940700A (fi) 1994-02-15

Similar Documents

Publication Publication Date Title
MX9204721A (es) Procedimiento para convertir polisacarido capsular bacterial que contiene lipido en polisacarido libre de lipido.
DE69620271D1 (de) Polyribosylribitol-phosphat enthaltende Haemophilus-influenzae-Typ-b-Impfstoffzubereitung und Verfahren zur deren Herstellung
Schultz et al. Evidence for a new type of outer membrane lipid in oral spirochete Treponema denticola: functioning permeation barrier without lipopolysaccharides
LV12329A (lv) Dokozaheksaenoskabes un dokozapentaenoskabes iegusanas panemiens
SI0756461T1 (en) Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same
ATE44238T1 (de) Vakzine fuer gramnegative bakterien und verfahren zur herstellung derselben.
DE69226495D1 (de) Verfahren zur herstellung überzogener mikrobieller pestizide und so hergestellte pestizide
ATE209687T1 (de) Enzymatischer prozess zur herstellung eines synthetischer esters aus einem pflanzlischen öl
ES2073706T3 (es) Nuevos derivados de acidos fosfono-alcanopolicarboxilicos y sus utilizaciones.
FI885464A (fi) Asyylioksiasyylihydrolaasi ja sen käyttö
CA2018709A1 (en) Process for removing bacterial endotoxin from gram-negative polysaccharides
PT97773A (pt) Processo para a preparacao de oxazolidinonas e de composicoes farmaceuticas que as contem
EP0960943A4 (en) MEDIUM FOR THE CULTURE OF MICROORGANISMS AND METHOD FOR PRODUCING UNSATURATED FATTY ACIDS OR LIPIDS CONTAINING THE SAME
AU2220695A (en) Process for the resolution of etodolac using glucamine derivatives
HUT60299A (en) Process for producing alkenyl succinimides and their application as lubricant additive
DK0535939T3 (da) Fremgangsmåde til fremstilling af omega 9-type polyumættet fedtsyre
MX9204037A (es) Composicion derivado de un succinoglicano, su procedimiento de preparacion y sus aplicaciones.
DE69112716D1 (de) Verfahren zur biologischen Herstellung einer Hydroxyvitamin-D-Verbindung.
DE69511066D1 (de) Wärmeschrumpfbarer gegenstand
AU5449890A (en) Way and plant for producing alcohol for motor fuel from cellulose bearing waste and rest materials
DE59103718D1 (de) Verfahren zur herstellung von l-lysin produzierenden mikroorganismen.
DE59104583D1 (de) Gleitlager zur Aufnahme von radialen und axialen Lagerkräften und Verfahren zu dessen Herstellung.
DE69927247D1 (de) Verfahren zur herstellung von fleischprodukten
TR199901856T2 (xx) Trigliserit ya�lar�n�n ayr��t�r�lmas�.
Rudik et al. Cultivarea algei rosii porphyridium cruentum si perspectivele utilizarii ei in fotobiotehnologie.